Role of pancreatic duct stenting in the treatment of chronic pancreatitis

Vitale, Gary C.; Cothron, Kyle J.; Vitale, E. A.; Rangnekar, N.; Zavaleta, Carlos M.; Larson, Gerald M.; Binford, John R.; Hammond, Bethanie

doi:10.1007/s00464-003-8933-z

Cited by 64 publications

(33 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Early removal of a pancreatic stent can be considered if it has no effect on pain. Currently there are two strategies in pancreatic stenting: either removing the pancreatic stent after a period of 6−12 months irrespective of the resolution of the stricture of the main pancreatic duct or substitution of pancreatic stents until stricture disappearance [175,176,[193][194][195][196][197][198][199][200]. Long-term pain relief was experienced by two-thirds of patients after 12 months stenting, though resolution of the stricture was observed in a minority of patients [176,193].…”

Section: E3: Is Endoscopic Therapy Indicated In Chronic Pancreatitismentioning

confidence: 99%

Italian consensus guidelines for chronic pancreatitis

Frulloni

Falconi

Gabbrielli

et al. 2010

Digestive and Liver Disease

166

112

View full text Add to dashboard Cite

This paper gives practical guidelines for diagnosis and treatment of chronic pancreatitis. Statements have been elaborated by working teams of experts, by searching for and analysing the literature, and submitted to a consensus process by using a Delphi modified procedure. The statements report recommendations on clinical and nutritional approach, assessment of pancreatic function, treatment of exocrine pancreatic failure and of secondary diabetes, treatment of pain and prevention of painful relapses. Moreover, the role of endoscopy in approaching pancreatic pain, pancreatic stones, duct narrowing and dilation, and complications was considered. Recommendations for most appropriate use of various imaging techniques and of ultrasound endoscopy are reported. Finally, a group of recommendations are addressed to the surgical treatment, with definition of right indications, timing, most appropriate procedures and techniques in different clinical conditions and targets, and clinical and functional outcomes following surgery. © 2010 Editrice Gastroenterologica Italiana S.r.l

show abstract

Section: E3: Is Endoscopic Therapy Indicated In Chronic Pancreatitismentioning

confidence: 99%

Italian consensus guidelines for chronic pancreatitis

Frulloni

Falconi

Gabbrielli

et al. 2010

Digestive and Liver Disease

166

112

View full text Add to dashboard Cite

show abstract

“…Según nuestro hallazgos y de acuerdo a varios autores 15,16,17 hay que realizar colangiografia intraoperatoria a todos los pacientes de etiología biliar, para evitar la litiasis residual y prevenir la pancreatitis recurrente, que oscilaria entre 13 a 73%. 18 Los pacientes que tuvieron infección de la necrosis del páncreas, 18 fueron drenados en forma percutánea y tuvieron una evolución favorable, 4 pacientes fueron operados con cirugía convencional, 3 pacientes fueron tratados solo con antibióticos.…”

Section: Discussionunclassified

Acute Pancreatitis: Our Results, in 350 Cases Applying the Petrov Classification

Bogado¹,

Sotomayor²,

Grance³

et al. 2016

Rev. Cir. Parag

View full text Add to dashboard Cite

RESUMENAntecedentes: Una de las novedades en la pancreatitis aguda es la nueva clasificación de gravedad. La misma se fundamenta en 2 principios básicos fundamentales, y son la necrosis (peri) pancreática e insuficiencia orgánica. Cuando estos 2 principios se aplican, aparecen 4 categorías de gravedad: pancreatitis aguda leve, moderada, grave y crítica. Ojetivos: Describir nuestros resultados, aplicando la clasificación de Petrov. Pacientes y mé-todos: Pacientes adultos con diagnósticos de pancreatitis aguda que ingresaron en el servicio de cirugía general desde abril del 2013 al abril del 2015, es un estudio retrospectivo de datos recolectados prospectivamente. Resultados: Fueron ingresados 350 pacientes,de los cuales 72% fueron mujeres. La etiología fue biliar en el 93%. Entre las leves y moderadas ocupo el 82%. Encontramos 18,4% de litiasis coledociana. El 72% de la necrosis pancreática infectada fue manejado con drenaje percutáneo. No hubo mortalidad en las leves y moderadas. Mortalidad en las graves 10% y 55% en las críticas. Conclusiones: Nuestra pancreatitis son predominantemente de origen biliar, sexo femenino. La clasificación de Petrov es un sistema muy bueno para estratificar la gravedad de la pancreatitis aguda, porque utiliza factores reales para definirlos.Palabras claves: Pancreatitis aguda, Petrov, necrosis pán-creatica infectada. ABSTRACT Background:One of the novelties in acute pancreatitis is the new severity classification. It is based on two fundamental principles, these factors are necrosis (peri) pancreatic and organ failure. Acute mild, moderate, severe and critical pancreatitis: When these two principles are applied, 4 categories of severity appear.Objetives: Describe our results, applying the Petrov classification. Patients and Methods: Adult patients with a diagnosis of acute pancreatitis admitted to the general surgery from April 2013 to April 2015, is a retrospective study of data collected prospectively. Results: 350 patients were admitted, of which 72% were mujeres. The etiology was biliary in 93% .Among mild and moderate occupy 82%. We found 18.4% of cholelithiasis. 72% of infected pancreatic necrosis was managed with percutaneous drainage. There was no mortality in mild and moderate. Mortality in severe 10% and 55% in the critical. Conclusions: Our pancreatitis are predominantly biliary, female and classification of Petrov, is a good system to stratify the severity of acute pancreatitis, because it uses real factors of gravity.

show abstract

“…In chronic pancreatitis patients with dominant stricture, pain relief was obtained in 52%-95% of cases over a follow-up ranging from 8 to 72 mo [1,[7][8][9][10][11][12][13][14][15][16][17][18][19] . Stenting was also associated with weight gain and fewer hospital visits.…”

Section: Chronic Pancreatitismentioning

confidence: 99%

Endoscopic pancreatic duct stent placement for inflammatory pancreatic diseases

Alberto¹,

Testoni²

2007

WJG

View full text Add to dashboard Cite

The role of endoscopic therapy in the management of pancreatic diseases is continuously evolving; at present most pathological conditions of the pancreas are successfully treated by endoscopic retrograde cholangiopancreatography (ERCP) or endoscopic ultrasound (EUS), or both. Endoscopic placement of stents has played and still plays a major role in the treatment of chronic pancreatitis, pseudocysts, pancreas divisum, main pancreatic duct injuries, pancreatic fistulae, complications of acute pancreatitis, recurrent idiopathic pancreatitis, and in the prevention of post-ERCP pancreatitis. These stents are currently routinely placed to reduce intraductal hypertension, bypass obstructing stones, restore lumen patency in cases with dominant, symptomatic strictures, seal main pancreatic duct disruption, drain pseudocysts or fluid collections, treat symptomatic major or minor papilla sphincter stenosis, and prevent procedure-induced acute pancreatitis. The present review aims at updating and discussing techniques, indications, and results of endoscopic pancreatic duct stent placement in acute and chronic inflammatory diseases of the pancreas.

show abstract

Role of pancreatic duct stenting in the treatment of chronic pancreatitis

Abstract: The findings of this study support the use of pancreatic duct stenting as an option before surgical intervention for these difficult-to-manage patients with chronic pancreatitis.

Cited by 64 publications

References 13 publications

Italian consensus guidelines for chronic pancreatitis

Italian consensus guidelines for chronic pancreatitis

Acute Pancreatitis: Our Results, in 350 Cases Applying the Petrov Classification

Endoscopic pancreatic duct stent placement for inflammatory pancreatic diseases

Contact Info

Product

Resources

About